AMAM
Ambrx Biopharma Inc
AMAM
AMAM
Delisted
AMAM was delisted on the 6th of March, 2024.
44 hedge funds and large institutions have $568M invested in Ambrx Biopharma Inc in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
28% less capital invested
Capital invested by funds: $789M → $568M (-$220M)
Holders
44
Holding in Top 10
3
Calls
$17.6M
Puts
$4.66M
Top Buyers
| 1 | +$27.6M | |
| 2 | +$21.1M | |
| 3 | +$3.95M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$3.54M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$3.3M |
Top Sellers
| 1 | -$37.3M | |
| 2 | -$11.6M | |
| 3 | -$5.76M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.17M |
| 5 |
Holocene Advisors
New York
|
-$4.91M |